Janssen Ignored Nerve Damage Risk Of Levaquin, Suit Claims
Drugmaker Janssen Pharmaceuticals and parent company Johnson & Johnson were hit with a lawsuit Monday in Pennsylvania federal court alleging the drugmaker mislabeled and continued to market an antibiotic drug despite...To view the full article, register now.
Already a subscriber? Click here to view full article